Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

BioMedomics Inc Company Overview 4

BioMedomics Inc Company Snapshot 4

BioMedomics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

BioMedomics Inc – Pipeline Analysis Overview 7

BioMedomics Inc - Key Facts 7

BioMedomics Inc - Major Products and Services 8

BioMedomics Inc Pipeline Products by Development Stage 9

BioMedomics Inc Pipeline Products Overview 11

CLIA-Waived Point of Care Test - Testosterone 11

CLIA-Waived Point of Care Test - Testosterone Product Overview 11

CLIA-Waived Point of Care Test - Vitamin D 12

CLIA-Waived Point of Care Test - Vitamin D Product Overview 12

Next Generation POC Reader 13

Next Generation POC Reader Product Overview 13

Point of Care Test - Troponin 14

Point of Care Test - Troponin Product Overview 14

Rapid Drug Overdose Test - Cocaine 15

Rapid Drug Overdose Test - Cocaine Product Overview 15

Rapid Drug Overdose Test - Methamphetamine 16

Rapid Drug Overdose Test - Methamphetamine Product Overview 16

Rapid Drug Overdose Test - Morphine 17

Rapid Drug Overdose Test - Morphine Product Overview 17

Rapid Drug Overdose Test - PCP 18

Rapid Drug Overdose Test - PCP Product Overview 18

Rapid Drug Overdose Test - THC 19

Rapid Drug Overdose Test - THC Product Overview 19

Rapid Quantitative Acetaminophen Detection Assay 20

Rapid Quantitative Acetaminophen Detection Assay Product Overview 20

Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test 21

Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test Product Overview 21

Sickle SCAN 22

Sickle SCAN Product Overview 22

TR-LFIA Diagnostic Platform 23

TR-LFIA Diagnostic Platform Product Overview 23

BioMedomics Inc - Key Competitors 24

BioMedomics Inc - Key Employees 25

BioMedomics Inc - Locations And Subsidiaries 26

Head Office 26

Recent Developments 27

BioMedomics Inc, Recent Developments 27

Sep 22, 2015: Sickle SCAN Successfully Validated in Laboratory Testing 27

Aug 13, 2015: BioMedomics Receives CE Mark Approval for alpha-Thal SCAN 27

Feb 13, 2015: BioMedomics Receives CE Mark Approval for Sickle SCAN 27

Appendix 28

Methodology 28

About GlobalData 31

Contact Us 31

Disclaimer 31

Summary

BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops and markets immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube based POC platform. It offers products such as alpha-thal scan, rapid diagnostic test for alpha-thalassemia; sickle scan, rapid diagnostic test for sickle cell disease and trait; and others. The company’s pipeline products are used for treating Troponin, vitamin D deficiency and testosterone deficiency. BioMedomics is headquartered in Durham, North Carolina, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BioMedomics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company